Cigna Corporation (NYSE:CI) insider Michael W. Triplett sold 10,417 shares of Cigna Corporation stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $197.77, for a total value of $2,060,170.09. Following the sale, the insider now directly owns 32,347 shares in the company, valued at $6,397,266.19. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shares of Cigna Corporation (NYSE:CI) traded down $0.47 during mid-day trading on Wednesday, reaching $197.14. The company’s stock had a trading volume of 1,263,100 shares, compared to its average volume of 1,361,488. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.39 and a current ratio of 0.39. Cigna Corporation has a 12 month low of $131.03 and a 12 month high of $206.45. The firm has a market capitalization of $48,600.00, a P/E ratio of 19.04, a P/E/G ratio of 1.51 and a beta of 0.49.

Cigna Corporation (NYSE:CI) last issued its earnings results on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, beating the Zacks’ consensus estimate of $2.36 by $0.47. Cigna Corporation had a return on equity of 18.85% and a net margin of 5.74%. The company had revenue of $10.38 billion during the quarter, compared to the consensus estimate of $10.17 billion. During the same period in the previous year, the firm posted $1.94 earnings per share. Cigna Corporation’s quarterly revenue was up 5.1% compared to the same quarter last year. analysts anticipate that Cigna Corporation will post 10.34 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Cigna Corporation (CI) Insider Sells $2,060,170.09 in Stock” was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/11/15/cigna-corporation-ci-insider-sells-2060170-09-in-stock.html.

A number of hedge funds have recently modified their holdings of CI. Capstone Investment Advisors Netherlands B.V. acquired a new position in Cigna Corporation in the second quarter valued at approximately $106,000. Saratoga Research & Investment Management acquired a new position in Cigna Corporation in the third quarter valued at approximately $112,000. Horan Capital Advisors LLC. acquired a new position in Cigna Corporation in the third quarter valued at approximately $123,000. Parallel Advisors LLC boosted its stake in Cigna Corporation by 62.3% in the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock valued at $139,000 after acquiring an additional 307 shares during the period. Finally, Acrospire Investment Management LLC boosted its stake in Cigna Corporation by 66.7% in the second quarter. Acrospire Investment Management LLC now owns 1,000 shares of the health services provider’s stock valued at $167,000 after acquiring an additional 400 shares during the period. Institutional investors own 89.69% of the company’s stock.

A number of brokerages have recently issued reports on CI. Royal Bank Of Canada reaffirmed a “buy” rating and set a $185.00 target price on shares of Cigna Corporation in a research report on Wednesday, August 9th. Deutsche Bank AG lifted their target price on Cigna Corporation from $180.00 to $190.00 and gave the stock a “buy” rating in a research report on Monday, August 7th. Zacks Investment Research lowered Cigna Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday, August 8th. Citigroup Inc. lifted their target price on Cigna Corporation from $185.00 to $198.00 and gave the stock a “buy” rating in a research report on Monday, August 7th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and set a $190.00 target price (down from $199.00) on shares of Cigna Corporation in a research report on Friday, August 4th. Three analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $201.50.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Insider Buying and Selling by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.